Gamida Cell
1 known investors
Gamida Cell develops allogeneic cell therapy products using its proprietary nicotinamide (NAM) technology to enhance and expand cells for treating patients with hematologic and non-hematologic conditions. The company focuses on research, development, manufacturing, and commercialization of cell therapies for malignant and non-malignant hematological diseases.
BiotechHealthtechLongevity